BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1348586)

  • 1. Polymorphism of the tumor necrosis factor region in relation to disease: an overview.
    Verjans GM; Messer G; Weiss EH; van der Linden SM; Kijlstra A
    Rheum Dis Clin North Am; 1992 Feb; 18(1):177-86. PubMed ID: 1348586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The -308.1 polymorphism in the promoter region of the tumor necrosis factor gene is associated with ankylosing spondylitis independent of HLA-B27.
    McGarry F; Walker R; Sturrock R; Field M
    J Rheumatol; 1999 May; 26(5):1110-6. PubMed ID: 10332976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF-238A promoter polymorphism contributes to susceptibility to ankylosing spondylitis in HLA-B27 negative patients.
    González S; Torre-Alonso JC; Martínez-Borra J; Fernández Sánchez JA; López-Vazquez A; Rodríguez Pérez A; López-Larrea C
    J Rheumatol; 2001 Jun; 28(6):1288-93. PubMed ID: 11409121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine gene polymorphisms and genetic association with coeliac disease in the Finnish population.
    Woolley N; Mustalahti K; Mäki M; Partanen J
    Scand J Immunol; 2005 Jan; 61(1):51-6. PubMed ID: 15644122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA sequence polymorphism at the human tumor necrosis factor (TNF) locus. Numerous TNF/lymphotoxin alleles tagged by two closely linked microsatellites in the upstream region of the lymphotoxin (TNF-beta) gene.
    Nedospasov SA; Udalova IA; Kuprash DV; Turetskaya RL
    J Immunol; 1991 Aug; 147(3):1053-9. PubMed ID: 1861069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms within the tumor necrosis factor-alpha promoter region in patients with HLA-B27-associated uveitis: association with susceptibility and clinical manifestations.
    El-Shabrawi Y; Wegscheider BJ; Weger M; Renner W; Posch U; Ulrich S; Ardjomand N; Hermann J
    Ophthalmology; 2006 Apr; 113(4):695-700. PubMed ID: 16581430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [TaqI restriction polymorphism and the HLA-B27 allele in ankylosing spondylitis].
    Huetz F; Lucotte G; Kahan A; Amor B
    Rev Rhum Mal Osteoartic; 1987 Mar; 54(3):175-8. PubMed ID: 2884722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the class I HLA 9.2-kb PVU II restriction fragment length polymorphism. Linkage to HLA-A and lack of disease association.
    Ahearn JM; Calomiris JJ; Wigley FM; Jabs DA; Bias WB; Hochberg MC
    Arthritis Rheum; 1989 Jul; 32(7):870-6. PubMed ID: 2568835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of different tumor necrosis factor alpha promoter allele frequencies with ankylosing spondylitis in HLA-B27 positive individuals.
    Höhler T; Schäper T; Schneider PM; Meyer zum Büschenfelde KH; Märker-Hermann E
    Arthritis Rheum; 1998 Aug; 41(8):1489-92. PubMed ID: 9704649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of tumour necrosis factor-alpha, lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with Löfgren's syndrome in Czech patients with sarcoidosis.
    Mrazek F; Holla LI; Hutyrova B; Znojil V; Vasku A; Kolek V; Welsh KI; Vacha J; du Bois RM; Petrek M
    Tissue Antigens; 2005 Feb; 65(2):163-71. PubMed ID: 15713215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restriction fragment length polymorphism of T cell receptor alpha and beta chain genes in patients with ankylosing spondylitis.
    Durand JP; el-Zaatari FA; Krieg AM; Taurog JD
    J Rheumatol; 1988 Jul; 15(7):1115-8. PubMed ID: 2902224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA class II polymorphism: implications for genetic susceptibility to autoimmune disease.
    Gregersen PK
    Lab Invest; 1989 Jul; 61(1):5-19. PubMed ID: 2664347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interethnic studies of TNF polymorphisms confirm the likely presence of a second MHC susceptibility locus in ankylosing spondylitis.
    Milicic A; Lindheimer F; Laval S; Rudwaleit M; Ackerman H; Wordsworth P; Hohler T; Brown MA
    Genes Immun; 2000 Oct; 1(7):418-22. PubMed ID: 11196671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 6 gene promoter polymorphism is not associated with ankylosing spondylitis.
    Collado-Escobar MD; Nieto A; Matarán L; Raya E; Martín J
    J Rheumatol; 2000 Jun; 27(6):1461-3. PubMed ID: 10852271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polymorphism of the microsatellites and tumor necrosis factor genes in chronic inflammatory bowel diseases].
    Heresbach D; Ababou A; Bourienne A; Alizadeh M; Quelvennec E; Pagenault M; Dabadie A; Berre NH; Campion JP; Launois B; Gosselin M; Genetet B; Bretagne JF; Semana G
    Gastroenterol Clin Biol; 1997; 21(8-9):555-61. PubMed ID: 9587492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in the promoter region of tumor necrosis factor alpha (TNF-alpha) and the HLA-DRB1 locus in Mexican mestizo patients with ulcerative colitis.
    Yamamoto-Furusho JK; Uscanga LF; Vargas-Alarcón G; Rodríguez-Pérez JM; Zuñiga J; Granados J
    Immunol Lett; 2004 Aug; 95(1):31-5. PubMed ID: 15325795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic aspects of ankylosing spondylitis.
    Khan MA; Ball EJ
    Best Pract Res Clin Rheumatol; 2002 Sep; 16(4):675-90. PubMed ID: 12406434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association and interaction of the TNF-alpha gene with other pro- and anti-inflammatory cytokine genes and HLA genes in patients with type 1 diabetes from North India.
    Kumar R; Goswami R; Agarwal S; Israni N; Singh SK; Rani R
    Tissue Antigens; 2007 Jun; 69(6):557-67. PubMed ID: 17498265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HLA class I antigens: from molecular-genetic analysis to their role in the etiopathogenesis of various rheumatic diseases].
    Segal VE
    Mol Gen Mikrobiol Virusol; 1987 Oct; (10):3-14. PubMed ID: 3323898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunogenetics of chronic ulcerative colitis].
    Yamamoto-Furusho JK
    Rev Invest Clin; 2003; 55(6):705-10. PubMed ID: 15011740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.